NEWS
New Feature!!!! University Subject Rankings in 12 branches
FOR SCIENTIST REGISTRATION FOR INSTITUTIONAL BULK REGISTRATION
FOR EDIT YOUR UNIVERSITY / INSTITUTION PAGE
Some differences of the AD Scientific Index
New Feature!!!! University Subject Rankings in 12 branches
List without CERN, Statistical Data etc. Only in AD Scientific Index
New Feature!!!! University Subject Rankings in 12 branches
AD
Scientific Index 2024
About Us
Methodology
Compare & Choose
Contact - FAQ
login
Login
person_add
Register
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
school
University Rankings
subject
University Subject Rankings
insights
Subject Rankings
place
Country Rankings
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
local_fire_department
Country Top Lists
Jennifer Winkelmann
Memorial Sloan Kettering Cancer Center - Indore / United States
Others
AD Scientific Index ID: 4844992
Edit Form
Registration, Add Profile,
Premium Membership
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Congresses (0)
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Jennifer Winkelmann's MOST POPULAR ARTICLES
1-)
Phase I study of flavopiridol with oxaliplatin and fluorouracil/leucovorin in advanced solid tumorsD Rathkopf, MA Dickson, DR Feldman, RD Carvajal, MA Shah, N Wu, ...Clinical Cancer Research 15 (23), 7405-7411, 2009662009
2-)
Pharmacokinetic and pharmacodynamic phase I study of PS-341 and gemcitabine in patients with advanced solid tumorsDP Ryan, JP Eder, J Winkelmann, T Lynch, J Supko, LJ Appleman, ...Proc Am Soc Clin Oncol 21, 95a, 2002332002
3-)
Programmed death 1 immune checkpoint inhibitorsMS Trivedi, B Hoffner, JL Winkelmann, ME Abbott, O Hamid, RD CarvajalClin. Adv. Hematol. Oncol 13 (12), 858-868, 2015272015
4-)
Parallel phase Ib studies of two schedules of buparlisib (BKM120) plus carboplatin and paclitaxel (q21 days or q28 days) for patients with advanced solid tumorsDM Hyman, AE Snyder, RD Carvajal, JF Gerecitano, MH Voss, AL Ho, ...Cancer chemotherapy and pharmacology 75, 747-755, 2015242015
5-)
A phase I trial of erlotinib, gemcitabine and radiation for patients with locally advanced, unresectable pancreatic cancerJS Kortmansky, EM O’Reilly, BD Minsky, SA Puleio, J Winkelmann, ...Journal of Clinical Oncology 23 (16_suppl), 4107-4107, 2005242005
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept